Filgrastim treatment of HIV-infected patients improves neutrophil function.
The effect of Filgrastim (recombinant methionyl human granulocyte colony-stimulating factor) treatment on neutrophil function was studied in HIV-infected patients. Filgrastim therapy significantly increased oxidative capacity of neutrophils, increased bacterial killing, and reduced accelerated apoptosis of neutrophils observed in this patient population.